Also, in this context, we previously identified CCCTC-binding factor (CTCF)-binding enrichment within the distal promoter region of SPRY2 that was hypomethylated in CRC patients and may therefore serve as a transcriptional activator. This evidence concerns the gene SPRY2 and colorectal carcinoma.